PLIANT THERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Pliant Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2019 to Q3 2024.
  • Pliant Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 60.8M shares, a 1.6% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 60.8M +959K +1.6% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 60.4M +1.2M +2.03% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 60.3M +1.34M +2.27% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 59.9M +11M +22.4% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 59.9M +11.1M +22.9% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 59.2M +23M +63.7% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 59M +22.8M +63.1% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 48.9M +12.9M +35.6% Dec 31, 2022 10-K 2024-02-27
Q3 2022 48.7M +12.8M +35.5% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 36.2M +328K +0.92% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 36.2M +414K +1.16% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 36.1M +531K +1.49% Dec 31, 2021 10-K 2023-03-09
Q3 2021 36M +512K +1.44% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 35.9M +427K +1.2% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 35.7M Mar 31, 2021 10-Q 2021-05-10
Q4 2020 35.6M +33.7M +1826% Dec 31, 2020 10-K 2022-03-01
Q3 2020 35.5M Sep 30, 2020 10-Q 2020-11-10
Q2 2020 35.4M Jun 30, 2020 10-Q 2020-08-11
Q4 2019 1.85M Dec 31, 2019 10-K 2021-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.